Trosyd 1% - powder for the treatment of dermatomycoses 30 g

Product Description

Giuliani

Skin powder

TROSYD 1% Cream - 1% Skin powder - 1% Skin emulsion Dermatomycosis caused by dermatophytes, yeasts and other fungi sensitive to Tioconazole. Skin infections caused by Gram-positive bacteria sensitive to the drug. Due to its concomitant antifungal and antibacterial activity, it is particularly indicated for mixed skin infections. TROSYD 28% Cutaneous solution for nail use Onychomycosis caused by dermatophytes and yeasts. Due to its concomitant antibacterial activity, it is particularly indicated for mixed infections. TROSYD 1% Skin Solution TROSYD skin solution is indicated for the topical treatment of skin infections caused by fungi (dermatophytes and yeasts), even when associated with superinfections by sensitive Gram-positive bacteria, as an adjuvant to therapy with other specific topical preparations. The skin solution allows for easier application in more extensive dermatomycoses and provides medicated cleansing of glabrous or hairy skin. Furthermore, by allowing treatment of a large skin surface, it makes it possible to eliminate the pathogen not only where morphological skin variations are detectable but also where the skin is apparently healthy.

Dosage

1% Cream - 1% Powder - 1% Skin Emulsion TROSYD should be applied with a light massage twice a day, morning and evening, on the affected skin and the immediately surrounding area. - In intertrigo areas, TROSYD 1% Cream should be applied in small quantities and spread well to avoid maceration. TROSYD 1% Skin Powder is available in a container so it can be applied directly in a uniform layer. TROSYD 1% Skin Emulsion should be applied with the fingertips and a cotton swab. The duration of treatment required to achieve healing varies from patient to patient and depending on the infectious agent and the site of infection. A 7-day treatment is usually sufficient to achieve healing in most patients with Pityriasis versicolor, while up to 6 weeks of treatment may be necessary in cases of severe forms of Tinea pedis (athlete's foot), especially the chronic hyperkeratotic clinical variety. The duration of treatment required for dermatophyte infections in other locations, for candidiasis and erythrasma is usually between 2 and 4 weeks. Trosyd 28% Cutaneous Solution for Nail Use: TROSYD should be applied to the infected nail and the periungual region twice daily, morning and evening, using the appropriate brush. The solvent contained in Trosyd dries in 5 minutes, leaving a thin, transparent, oily film. Even if this film is accidentally removed, this does not reduce the drug's effectiveness, and therefore it is not necessary to reapply it. It is recommended not to use an occlusive dressing. The duration of treatment required to achieve healing varies from patient to patient and depends on the infectious agent and the extent of the lesion. Generally, therapy can last on average up to 6 months, but can be extended up to a year. Trosyd 1% Cutaneous Solution: Upon contact with the skin, it forms a foaming solution. Use the amount of solution needed for the skin surface area to be treated, using the product as a liquid cleanser, once a day, and rinse with water a few minutes after application. TROSYD 1% cutaneous solution must be used in conjunction with a specific topical antifungal treatment, applied after using the solution. The duration of treatment required to achieve healing varies depending on the infectious agent and the site of infection and is usually between two and four weeks. At the doctor's discretion, treatment with the cutaneous solution may be continued even after the end of other specific topical therapies in order to reduce the risk of recurrence.

Active Ingredients

TROSYD 1% Cream 1 g of cream contains: Active ingredient: Tioconazole 10 mg. TROSYD 1% Cutaneous powder 100 g of powder contain: Active ingredient: Tioconazole 1 g. TROSYD 1% Cutaneous emulsion 100 g of emulsion contain: Active ingredient: Tioconazole 1 g. TROSYD 28% Cutaneous solution for nail use 100 g of solution contain: Active ingredient: Tioconazole 28 g. TROSYD 1% Cutaneous solution Each 10 g sachet of solution contains: Active ingredient: Tioconazole 0.10 g.

Excipients

1% Cream: polysorbate 60, sorbitan monostearate, cetostearyl alcohol, 2-octyldodecanol, cetyl ester wax, benzyl alcohol, purified water. 1% Cutaneous powder: talc, magnesium myristate, kaolin, precipitated silica. 1% Skin emulsion: emulsifying wax, cetyl alcohol, cetylstearyl alcohol, coconut oil, glyceryl stearate and palmitate, propylene glycol, benzyl alcohol, purified water. 28% Cutaneous solution for nail use: undecylenic acid, ethyl acetate. 1% Cutaneous solution: monoethanolamine lauryl sulfate, lecithinamide, polyglycoleum, undebenzophene, lactic acid, soothing lipoessential, purified water.

Contraindications

Hypersensitivity to the active substance or to any of the excipients. Pregnancy (for Trosyd cutaneous solution for nail use): see point 4.6.

Warnings

The application of products for topical use, especially if prolonged, can cause skin irritation. give rise to sensitization phenomena.

Pregnancy

There are no adequate and well-controlled studies on the use of the medicine during pregnancy or breastfeeding. Therefore, the medicine should be used only if necessary, under the direct supervision of a doctor, after evaluating the expected benefit for the mother in relation to the possible risk to the fetus or infant. Trosyd cutaneous solution for nail use: Although systemic absorption after topical administration is negligible, however, since the treatment of onychomycosis can continue for many months, the use of Trosyd cutaneous solution for nail use during pregnancy is contraindicated.

Side Effects

In very rare cases, mild and transient local irritation has been observed. However, in the presence of hypersensitivity reactions, treatment should be discontinued and appropriate therapy instituted.

Overdose

No cases of overdose have been reported so far.

Interactions

No interactions or incompatibilities with other medications are known so far.

Storage

No special precautions for storage.